Lewis Sanders
Sanders Capital
Sanders Capital Portfolio 13F
Lewis Sanders Holdings Activity
- Portfolio value:
- $54.11B≈ (+$7B≈)
- Previous value:
- $47.32B≈
- # of changes:
- 45
- New positions:
- 2
- Reported for:
- 31 Dec 2023 (Q4)
- Latest filing date:
- 12 Feb 2024
Sanders Capital has disclosed a total of 45 changes to the portfolio in the (2023 Q4) SEC report(s): increased the number of shares of 29, bought 2 totally new, decreased the number of shares of 12 and completely sold out 2 position(s).
What stocks did Lewis Sanders buy in 2023 Q4?
During 2023 Q4 Lewis Sanders has bought 31 securities out of which top 5 purchases (by % change to portfolio) were (META) Meta Platforms Inc (added shares +2.42%), (MSFT) Microsoft Corp (added shares +2.23%), (TSM) Taiwan Semiconductor Manufacturing (added shares +3.49%), (GOOG) Alphabet Inc, CL-C (added shares +2.93%) and (AAPL) Apple Inc (added shares +2.36%).
In the 2023 Q4 report(s) the following changes have been made to the top investments: (META) Meta Platforms Inc (added shares +2.42%), (MSFT) Microsoft Corp (added shares +2.23%), (TSM) Taiwan Semiconductor Manufacturing (added shares +3.49%), (GOOG) Alphabet Inc, CL-C (added shares +2.93%) and (AAPL) Apple Inc (added shares +2.36%).
45 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Humana Inc
|
new
|
+1,068,783
|
1,068,783
|
+0.9%
|
$457.81
|
-19.95%($366.46)
|
0.90%
|
2023 Q4
|
≈ 0.25 years
|
|
|
|
Abbott Laboratories
|
new
|
+1,193,078
|
1,193,078
|
+0.24%
|
$110.07
|
-4.11%($105.55)
|
0.24%
|
2023 Q4
|
≈ 0.25 years
|
|
|
|
AstraZeneca PLC
|
+39.04%
|
+4,122,965
|
14,684,066
|
+0.51%
|
$67.35
|
|
1.83%
|
2023 Q3
|
≈ 0.50 years
|
|
|
|
Baidu Inc
|
+7.12%
|
+44,571
|
670,604
|
+0.01%
|
$119.09
|
-7.41%($110.26)
|
0.15%
|
2022 Q4
|
≈ 1.25 years
|
|
|
|
RTX Corp
|
+6.78%
|
+677,520
|
10,674,438
|
+0.11%
|
$84.14
|
+155.63%($215.08)
|
1.66%
|
2023 Q1
|
≈ 1.00 year
|
|
|
|
Alibaba Group Holding Ltd
|
+5.45%
|
+819,019
|
15,848,257
|
+0.12%
|
$77.51
|
+57.55%($122.12)
|
2.27%
|
2023 Q2
|
≈ 0.75 years
|
|
|
|
Kroger Company
|
+4.96%
|
+1,123,427
|
23,786,389
|
+0.09%
|
$45.71
|
+26.69%($57.91)
|
2.01%
|
2023 Q1
|
≈ 1.00 year
|
|
|
|
Elevance Health Inc
|
+4.60%
|
+196,010
|
4,457,986
|
+0.17%
|
$471.56
|
-19.91%($377.65)
|
3.89%
|
2014 Q4
|
≈ 9.25 years
|
|
|
|
Schlumberger NV
|
+4.30%
|
+346,177
|
8,402,669
|
+0.03%
|
$52.04
|
-4.90%($49.49)
|
0.81%
|
2023 Q2
|
≈ 0.75 years
|
|
|
|
HCA Healthcare, Inc
|
+4.17%
|
+456,738
|
11,404,003
|
+0.23%
|
$270.68
|
+48.11%($400.90)
|
5.71%
|
2020 Q2
|
≈ 3.75 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.